In8bio Accounts Payable vs Non Currrent Assets Other Analysis
| INAB Stock | USD 0.32 0.01 3.03% |
In8bio financial indicator trend analysis is infinitely more than just investigating In8bio Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether In8bio Inc is a good investment. Please check the relationship between In8bio Accounts Payable and its Non Currrent Assets Other accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Accounts Payable vs Non Currrent Assets Other
Accounts Payable vs Non Currrent Assets Other Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of In8bio Inc Accounts Payable account and Non Currrent Assets Other. At this time, the significance of the direction appears to have very week relationship.
The correlation between In8bio's Accounts Payable and Non Currrent Assets Other is 0.2. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of In8bio Inc, assuming nothing else is changed. The correlation between historical values of In8bio's Accounts Payable and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of In8bio Inc are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Accounts Payable i.e., In8bio's Accounts Payable and Non Currrent Assets Other go up and down completely randomly.
Correlation Coefficient | 0.2 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Accounts Payable
An accounting item on the balance sheet that represents In8bio obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of In8bio Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Most indicators from In8bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into In8bio Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. The current year's Enterprise Value is expected to grow to about 39.9 M, whereas Selling General Administrative is forecasted to decline to about 7.8 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 788K | 1.1M | 2.5M | 2.6M | Total Operating Expenses | 14.7M | 28.5M | 30.3M | 16.3M |
In8bio fundamental ratios Correlations
Click cells to compare fundamentals
In8bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
In8bio fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 1.1M | 20.9M | 42.2M | 33.0M | 33.7M | 25.1M | |
| Total Current Liabilities | 647K | 2.6M | 2.3M | 5.8M | 5.4M | 3.1M | |
| Total Stockholder Equity | (346K) | 18.3M | 38.2M | 22.7M | 24.9M | 19.9M | |
| Property Plant And Equipment Net | 274K | 186K | 2.8M | 10.3M | 8.6M | 9.0M | |
| Net Debt | (610K) | (17.8M) | (34.6M) | (12.3M) | (16.4M) | (17.2M) | |
| Retained Earnings | (9.5M) | (18.0M) | (32.7M) | (61.2M) | (91.2M) | (86.7M) | |
| Accounts Payable | 560K | 620K | 395K | 2.1M | 924K | 918.3K | |
| Cash | 610K | 18.0M | 37.0M | 18.2M | 21.3M | 18.3M | |
| Non Current Assets Total | 367K | 2.8M | 3.2M | 10.8M | 9.1M | 5.0M | |
| Non Currrent Assets Other | 93K | 2.6M | 158K | 381K | 511K | 687.7K | |
| Cash And Short Term Investments | 610K | 18.0M | 37.0M | 18.2M | 21.3M | 18.3M | |
| Liabilities And Stockholders Equity | 1.1M | 20.9M | 42.2M | 33.0M | 33.7M | 25.1M | |
| Other Current Assets | 48K | 150K | 3.9M | 7.9M | 3.3M | 2.8M | |
| Other Stockholder Equity | 238K | 1.5M | 70.9M | 83.9M | 116.2M | 122.0M | |
| Total Liab | 1.5M | 2.6M | 4.0M | 10.3M | 8.8M | 5.2M | |
| Net Invested Capital | (9.2M) | (16.4M) | 38.2M | 22.7M | 24.9M | 26.2M | |
| Property Plant And Equipment Gross | 274K | 186K | 3.2M | 10.3M | 9.9M | 10.3M | |
| Total Current Assets | 763K | 18.1M | 39.0M | 22.2M | 24.6M | 20.1M | |
| Net Working Capital | 116K | 15.6M | 36.7M | 16.4M | 19.2M | 17.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether In8bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of In8bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of In8bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on In8bio Inc Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.74) | Return On Assets (0.78) | Return On Equity (1.80) |
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.